These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22583432)

  • 1. Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.
    Bademci G; Vance JM; Wang L
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):469-81. PubMed ID: 22583432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tyrosine hydroxylase in Parkinson's disease and in related disorders.
    Nagatsu T; Nakashima A; Ichinose H; Kobayashi K
    J Neural Transm (Vienna); 2019 Apr; 126(4):397-409. PubMed ID: 29995172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCH1 Deficiency Activates Brain Innate Immune Response and Impairs Tyrosine Hydroxylase Homeostasis.
    Larbalestier H; Keatinge M; Watson L; White E; Gowda S; Wei W; Koler K; Semenova SA; Elkin AM; Rimmer N; Sweeney ST; Mazzolini J; Sieger D; Hide W; McDearmid J; Panula P; MacDonald RB; Bandmann O
    J Neurosci; 2022 Jan; 42(4):702-716. PubMed ID: 34876467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of tyrosine hydroxylase in Parkinson's disease.
    Zhu Y; Zhang J; Zeng Y
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):350-8. PubMed ID: 22483316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease.
    Bademci G; Edwards TL; Torres AL; Scott WK; Züchner S; Martin ER; Vance JM; Wang L
    Hum Mutat; 2010 Oct; 31(10):E1767-71. PubMed ID: 20809526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function of tyrosine hydroxylase in the normal and Parkinsonian brain.
    Tolleson C; Claassen D
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):381-6. PubMed ID: 22483314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of GCH1 and TH mutations in Parkinson's disease.
    Rengmark A; Pihlstrøm L; Linder J; Forsgren L; Toft M
    Parkinsonism Relat Disord; 2016 Aug; 29():109-11. PubMed ID: 27185167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    Mov Disord; 1994 May; 9(3):337-9. PubMed ID: 7913740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of tyrosine hydroxylase in management of Parkinson's disease.
    Feve AP
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):450-5. PubMed ID: 22583428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of structural mutations of the tyrosine hydroxylase gene with schizophrenia and Parkinson's disease.
    Kunugi H; Kawada Y; Hattori M; Ueki A; Otsuka M; Nanko S
    Am J Med Genet; 1998 Mar; 81(2):131-3. PubMed ID: 9613851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Parkinson's - tyrosine hydroxylase and oxidative stress as points of interventions.
    Khan MS; Tabrez S; Priyadarshini M; Priyamvada S; Khan MM
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):369-80. PubMed ID: 22483312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.
    Jorge-Finnigan A; Kleppe R; Jung-Kc K; Ying M; Marie M; Rios-Mondragon I; Salvatore MF; Saraste J; Martinez A
    J Biol Chem; 2017 Aug; 292(34):14092-14107. PubMed ID: 28637871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson's disease.
    White RB; Thomas MG
    CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):340-9. PubMed ID: 22483315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease.
    Kasanuki K; Heckman MG; Diehl NN; Murray ME; Koga S; Soto A; Ross OA; Dickson DW
    Mov Disord; 2017 Nov; 32(11):1584-1593. PubMed ID: 28949048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease.
    Kastner A; Hirsch EC; Agid Y; Javoy-Agid F
    Brain Res; 1993 Mar; 606(2):341-5. PubMed ID: 8098254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
    Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of electroacupuncture stimulation of "Fengfu" (GV 16) and "Taichong" (LR 3) on expression of COX-2 and tyrosine hydroxylase in Substantia Nigra in rats with Parkinson's disease].
    Wang SJ; Fang JQ; Ma J; Zhou D; Wang YC; Gan SY; Sun GJ
    Zhen Ci Yan Jiu; 2013 Jun; 38(3):198-201. PubMed ID: 24006664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.